Nvidia submitted an application to Chinese regulators in recent weeks asking them to approve the company’s US$40 billion acquisition of Arm, according to a report from The Financial Times on Tuesday, June 8. Nvidia stated the regulatory process was confidential, but it remains confident that it will receive approval and “close in early 2022.”
When the deal was announced last September, Nvidia and Arm stated it would take approximately 18 months to go through. But Chinese regulators could take up to 18 months from now to reach a conclusion, according to the Chinese antitrust lawyers cited by the FT. Regulators in the UK, Europe, and the US are also probing the deal.
Arm has as a joint venture called “Arm China” with Chinese private equity firm Hopu Investments. Arm China is headquartered in Shanghai, meaning China’s Ministry of Commerce and China’s State Administration for Market Regulation will have the right to review the proposed Nvidia deal. China would review Nvidia’s acquisition of Arm in the second half of 2021.
Several people familiar with the thinking of China’s antitrust regulators said the country’s chipmakers, such as Huawei’s HiSilicon and Semiconductor Manufacturing International Corporation, as well as state-backed chip investment group E-Town Capital had opposed the deal. Their concerns stemmed from fears of handing greater control of the designs that underpinned a large portion of China’s chip industry to US-based Nvidia.
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI